高级检索
当前位置: 首页 > 详情页

TNFAIP2 promotes HIF1α transcription and breast cancer angiogenesis by activating the Rac1-ERK-AP1 signaling axis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China [2]Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models Human Dis Mech, Kunming, Peoples R China [3]Kunming Med Univ, Peking Univ, Yunnan Canc Hosp, Yunnan Key Lab Breast Canc Precis Med,Affiliated, Kunming, Peoples R China [4]Kunming Med Univ, Affiliated Hosp 1, Dept Pathol, Kunming, Yunnan, Peoples R China [5]Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Pathol, Zhengzhou, Henan, Peoples R China [6]Kunming Med Univ, Sch Continuing Educ, Kunming, Peoples R China [7]Kunming Med Univ, China Acad Biomed Engn, Acad Biomed Engn, Yunnan Key Lab Breast Canc Precis Med, Kunming, Peoples R China
出处:
ISSN:

摘要:
Angiogenesis is well known to play a critical role in breast cancer. We previously reported that TNFAIP2 activates Rac1 to promote triple-negative breast cancer (TNBC) cell proliferation, migration, and chemoresistance. However, the potential contribution of TNFAIP2 to tumor angiogenesis remains unknown. In this study, we demonstrated that TNFAIP2 promotes TNBC angiogenesis by activating the Rac1-ERK-AP1-HIF1 alpha signaling axis. Under hypoxia, TNFAIP2 activates Rac1 and ERK sequentially. Following that, ERK activates the AP-1 (c-Jun/Fra1) transcription factor. By employing chromatin immunoprecipitation and luciferase reporter assays, we showed that AP-1 directly interacts with the HIF1 alpha gene promoter, thereby enhancing its transcription. The combined application of ERK inhibitors, U0126 or trametinib, with the VEGFR inhibitor Apatinib, additively suppresses angiogenesis and tumor growth of HCC1806 in nude mice. These findings provide new therapeutic strategies for TNBC.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
最新[2023]版:
大类 | 1 区 生物学
小类 | 2 区 细胞生物学
JCR分区:
出版当年[2024]版:
最新[2023]版:
Q1 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China [2]Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models Human Dis Mech, Kunming, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [2]Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models Human Dis Mech, Kunming, Peoples R China [3]Kunming Med Univ, Peking Univ, Yunnan Canc Hosp, Yunnan Key Lab Breast Canc Precis Med,Affiliated, Kunming, Peoples R China [7]Kunming Med Univ, China Acad Biomed Engn, Acad Biomed Engn, Yunnan Key Lab Breast Canc Precis Med, Kunming, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:56916 今日访问量:0 总访问量:1772 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)